Sudarshan Pharma Industries Ltd — Important, 08-09-2025: Company Update

Sudarshan Pharma received an update on its Production Linked Incentive (PLI) Scheme approval for Vitamin B1 and B6 manufacturing. The company's request to relocate its greenfield projects from MIDC, Maharashtra, to GIDC, Gujarat, has been approved, addressing previous local resistance issues. This approval also includes a revised commercial operation deadline, requiring these projects to be commissioned by December 31, 2027. This change provides crucial flexibility for the company to establish its vital API manufacturing units, ensuring continued eligibility for the PLI scheme incentives, with all other criteria remaining unchanged.